Cello Health reports solid growth in 'strong' first half

(Sharecast News) - Advisory group Cello Health anticipates that full-year earnings will "at least be in line with current expectations" after recording growth across the whole business.
Cello said on Thursday that it had experienced a "strong first six months of the year", with good like-for-like growth in overall net revenues and headline profit before tax.

As a result, Cello witnessed "strong growth" in headline earnings per share, leaving it confident of achieving "a successful result in 2019".

Cello Signal, the company's marketing agency, revealed details of its solid start to the year, "with a performance similar to that in the first half of 2018".

The AIM-listed outfit also ended the period with a strong balance sheet, resulting in a net cash position at the end of June.

Looking forward, Cello said: "The group continues to assess suitable acquisitions in line with the strategic objective of further growing the Cello Health brand in the US in particular."

As of 0945 BST, Cello shares had sparked up 4.20% to 124p.